SOX2 and pancreatic ductal adenocarcinoma: Furthermore, both inducible overexpression and inducible knockdown of SOX2 in pancreatic ductal adenocarcinoma (PDAC) cells lead to a significant reduction in tumor growth, indicating that SOX2 levels in these cells are optimized to maximize tumor growth [15].